NVS451 Fusion protein

NVS451融合蛋白

Report date: 2022/01/14 13:23:58

Base Information

Drug NameNVS451 Fusion protein
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionInterleukin-17 inhibitors
TargetsInterleukin-17
Therapy Area/IndicationsPlaque psoriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesTraditional Chinese Medicine Zhongsheng Biological Technical Research Institute Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesTraditional Chinese Medicine Zhongsheng Biological Technical Research Institute Co Ltd
Inactive CompaniesN/A
Active IndicationsPlaque psoriasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A